BACK — Imac Holdings Share News
0.000.00%
Last trade - 00:00- $0.00m
- $3.79m
- $0.07m
Imac Holdings Inc Expected To Post A Loss Of 60 Cents A Share: Earnings Preview
Brief: Imac Holdings Inc Regains Compliance With Nasdaq Listing Requirements
Brief: IMAC Holdings Inc Says On Sept 6, Co Got Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Brief: IMAC Holdings, Inc. Announces 1-For-30 Reverse Stock Split
Imac Holdings Inc Reports Results For The Quarter Ended In June: Earnings Summary
Imac Holdings Inc Expected To Post A Loss Of 3 Cents A Share: Earnings Preview
Brief: Imac Holdings Receives Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Brief: IMAC Holdings - Theralink Will Merge With Newly-Formed Unit Of IMAC In A Stock-For-Stock Reverse Merger Transaction
Imac Holdings Inc Reports Results For The Quarter Ended In March: Earnings Summary
Imac Holdings Inc Expected To Post A Loss Of 5 Cents A Share: Earnings Preview
U.S. RESEARCH ROUNDUP-Huntington Bancshares, Popular, Welltower
Imac Holdings Inc Reports Results For The Quarter Ended In December: Earnings Summary
Imac Holdings Inc Expected To Post A Loss Of 7 Cents A Share: Earnings Preview
Brief: Imac Holdings Got Letter From Nasdaq Granting Co's Request For A 180-Day Extension To Regain Compliance With Minimum Bid Price Requirement
U.S. STOCKS ON THE MOVE-Netflix, crypto stocks, Albemarle
IMAC Holdings falls on wider Q3 losses
Brief: Imac Holdings Announces Q3 Results
Brief: Imac Holdings - On Sept 21, Co Received Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard From Nasdaq
Brief: Imac Holdings Announces Completion Of Third Cohort Of Its Phase 1 Clinical Study Of Umbilical Cord-Derived Mesenchymal Stem Cells